Navigating the complexities of encephalocraniocutaneous lipomatosis: a case series and review

Encephalocraniocutaneous lipomatosis (ECCL) is a rare congenital syndrome characterized by signs and symptoms involving the skin, eyes, and central nervous system (CNS) [1]. This disease, of unknown origin, poses a challenge both for diagnosis and treatment due to its rarity and the complexity of its manifestations [2]. Reported CNS manifestations include porencephalic cysts, cortical atrophy, and low-grade gliomas (LGG), which are consistently associated with developmental delay and mental retardation. Most problems focus on the spinal cord with diffuse lipomatosis. Specifically, clinical presentations can be compressive medullary or radiculopathy, resulting in consequences such as back pain, radiculopathy, or motor or sensory deficits. Neurosurgical interventions are complex and reserved for symptomatic cases. In this article, we analyze our series and reviews to evaluate the risk of surgery and neurological outcomes.

We present a series of three patients with ECCL treated at our institute between 2008 and 2023 (Table 1).

Patient A had scoliosis and a congenital lipoma in the right eye. Magnetic resonance imaging (MRI) revealed obstructive hydrocephalus and a spinal lipoma extending into the cervical-dorsal region (Fig. 1A), leading to the development of spastic tetraparesis and neurogenic bladder. Consequently, the patient underwent ventriculocisternostomy and later had two surgical procedures to remove the spinal lipoma. Following the surgical removal of the spinal lipoma, the patient developed kyphosis, requiring stabilization with spinal fusion. During follow-up, the patient developed a diffuse low-grade glioneuronal neoplasm throughout the brain, ultimately resulting in death.

Patient B presented with scoliosis and psychomotor delay. MRI revealed a spinal lipoma extending into the bulbo-dorsal region, along with hydrobulbia and hydromyelia (Fig. 1B). Surgical treatment was performed in two stages. After the first debulking surgery, the patient developed obstructive hydrocephalus, necessitating external ventricular drainage. The follow-up was concluded due to the patient’s death.

Patient C presented with lower back pain, motor disturbances, pigmented skin lesions, and attention deficits. MRI showed a cervical-lumbar spinal lipoma associated with kyphosis (Fig. 1C). The patient underwent three-stage surgical removal of the spinal lipoma, which included laminotomies and spinal stabilization. The patient’s follow-up is ongoing and has revealed an increase in kyphosis, requiring the use of a brace and rehabilitative therapy.

In all patients, surgical treatment was performed using a multi-step approach to better control the sequelae. Continuous neuromonitoring was applied during surgical procedures, including electroencephalogram (EEG), electromyogram (EMG), somatosensory evoked potentials (SSEPs), and motor evoked potentials (MEPs). Neuronal integrity was assessed through wake-up tests during surgery. This strategy was particularly crucial in the case of Patient C, as a loss of motor potentials in the lower limbs was detected during surgery (Fig. 2), allowing for immediate resolution of the complication.

ECCL is a multisystemic syndrome that involves three main components: cutaneous involvement is often one of the most apparent signs with various skin defects, including superficial lipomas, pigmented skin lesions, and facial angiofibromas [3, 4]. Central nervous system (CNS) involvement is the most severe component and the most important prognostic factor [5]. The distribution of lipomas is often widespread along the spinal cord, typically remaining stable throughout a patient’s life. Diagnosing ECCL can be challenging due to its clinical variability and similarity to other neurocutaneous diseases. Typically, it is made through a detailed clinical evaluation, neuroimaging studies, and sometimes genetic tests to identify specific genetic mutations associated [6]. ECCL is primarily associated with mosaic mutations in the FGFR1 gene as revealed by exome sequencing. The connection between mosaic mutations and developmental pathologies, with potential overlap in tumorigenesis-related signaling pathways like RAS-MAPK, is highlighted. However, not all ECCL cases are linked to identifiable FGFR1 mutations, suggesting the possibility of other genetic factors or mechanisms at play [4, 7, 8]. The treatment of ECCL is complex and aimed at managing the specific manifestations of the disease. In symptomatic cases, surgical removal may be necessary [9]. In particular, in patient with joint cervicomedullary involvement, posterior fossa craniectomy with cervical laminectomies is reserved for sleep apnea and upper deficits. Extensive laminectomy can lead to progressive kyphosis, necessitating consideration of surgical atlantoaxial transarticular screw fixation. In pre-operative scoliosis cases where debulking occurs in multiple steps, a complete posterior arthrodesis is indicated. Authors recommend subpial excision of lipomas, although intramedullary invasiveness may prevent complete removal [10]. Motor evoked potentials monitoring provides real-time feedback on the integrity of motor pathways, reducing the risk of neurological injury. Another reason for rigorous follow-up is that CNS malformations may increase morbidity and mortality [11]. We analyzed clinical cases of ECCL with spinal cord lipoma described in the literature (Table 2), and we found descriptions of 7 cases of ECCL with spinal cord lipoma. The extent of the lipoma ranged from involvement of only the dorsal portion to the entire spinal cord. Four patients underwent a surgical laminectomy with resection of the spinal lipoma [5, 10, 12, 13], but only one case was the procedure performed in two stages [10]. Of the cases described in the literature, only two presented obstructive hydrocephalus [10, 14], and in both cases, the patients underwent surgical treatment. In one case, an endoscopic third ventriculostomy (ETV) was performed [10], while in the other, a ventriculo-peritoneal shunt (VPS) was placed [14]. In fact, ventriculomegaly and macrocephaly are common findings in ECCL patients, but not all of them develop hydrocephalus. Hydrocephalus was diagnosed in approximately one-third of patients with ECCL, and ETV should be considered as the first option instead of VPS placement.

Early identification of ECCL is crucial for accurate diagnosis, effective symptomatic management, and better patient care, ultimately improving the quality of life for affected individuals [4]. In terms of treatment, the approach varies. In cases of associated hydrocephalus, ETV is usually preferred to alleviate intracranial pressure. The surgical approach for spinal cord lipomas is recommended in symptomatic cases and involves the removal of the lipoma, sometimes in multiple stages, to preserve nerve function. In our experience, we believe it is appropriate to perform surgical procedures in symptomatic cases, and we consider follow-up crucial not only to assess the growth of lipomatous lesions but also to prevent vertebral deformities; specifically, we anticipate cervical stabilization to prevent the development of kyphosis.